| Aminophylline |
![]() Last updated: 16/09/2025 |
![]() |
(Also known as: aminophylline dihydrate; aminophylline hydrous) |
|
|
|
Aminophylline is a bronchodilator used to relax muscles in the bronchial tubes of the lungs. It is the ethylenediamine salt of theophylline. | |
|---|---|---|
|
Used in veterinary medicine for animals suffering from asthma, bronchitis and chronic coughs | |
|
Dogs; Cats; Pigs; Horses; Cattle; Birds |
| Approval status |
|
Not approved | |
|---|---|---|
|
Approved |
| Chemical structure |
|
The main component of aminophylline theophyllin has structural analogs and related compounds that share similar properties. | |
|---|---|---|
|
C₁₆H₂₄N₁₀O₄ | |
|
CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N | |
|
- | |
|
FQPFAHBPWDRTLU-UHFFFAOYSA-N | |
|
InChI=1S/2C7H8N4O2.C2H8N2/c2*1-10-5-4(8-3-9-5)6(12)11(2)7(10)13;3-1-2-4/h2*3H,1-2H3,(H,8,9);1-4H2 | |
|
Yes |
| General status |
|
Bronchodilator, Cardiotonic, Medicinal drug | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Methylxanthine drug | ||||||||||||||
|
- | ||||||||||||||
|
- | ||||||||||||||
|
Synthetic | ||||||||||||||
|
Primary mode of action is as a bronchal smooth muscle relaxant | ||||||||||||||
|
[Phosphodiesterase type III and IV, Inhibitor], [Adenosine A2B receptor, Binder], [Adenosine, Blocker], [Histone deacetylase, Activator] | ||||||||||||||
|
317-34-0 | ||||||||||||||
|
12767-26-9; 442519-87-1 | ||||||||||||||
|
206-264-5 | ||||||||||||||
|
- | ||||||||||||||
|
- | ||||||||||||||
|
9433 | ||||||||||||||
|
Drugs for obstructive airway diseases; Aminophylline and adrenergics | ||||||||||||||
|
R03DA05 | ||||||||||||||
|
No | ||||||||||||||
|
- | ||||||||||||||
|
420.43 | ||||||||||||||
|
- | ||||||||||||||
|
1,3-dimethyl-7H-purine-2,6-dione; ethane-1,2-diamine | ||||||||||||||
|
theophylline compound with ethylenediamine (2:1) | ||||||||||||||
|
|
||||||||||||||
|
- | ||||||||||||||
|
- | ||||||||||||||
|
- | ||||||||||||||
|
A white or yellowish coloured powder with a faint ammonia-like smell | ||||||||||||||
| Commercial |
|
|
|||
|---|---|---|---|---|
|
Current | |||
|
1950s, first synthesised; 1990s, vet use adopted | |||
|
|
|||
|
|
|||
|
Usually administered orally or by injection | |||
|
The production of aminophylline involves forming a complex salt between theophylline, a xanthine derivative, and ethylenediamine. The process typically begins by dissolving theophylline in a suitable solvent followed by the gradual addition of ethylenediamine under controlled temperature and pH conditions. The reaction mixture is stirred and allowed to react, forming a stable 2:1 molar adduct of theophylline and ethylenediamine. After completion, the solution is cooled, filtered, and washed to remove excess reagents and byproducts. The final product is then dried and formulated. | |||
|
Published GHG data is not available for most pharmaceuticals. However, according to industry, global averages suggest producing 1 kg of a typical active pharmaceutical ingredient can range from 10 to 100 kg CO₂e for small molecule drugs and potentially up to 1000 kg CO₂e for complex biologicals such as vaccines, depending on the drug type, its formulation, complexity of synthesis, solvent recovery, and energy sources used. |
|
|
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
50000 | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
High | ||||||||
|
- | - | - | ||||||||
|
269 | E3 E = Manufacturers safety data sheets 3 = Unverified data of known source |
- | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
| - | |||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
No significant issues identified or anticipated | ||||||||||
| Degradation |
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below. | ||||||||||
|
- | ||||||||||
| Soil adsorption and mobility |
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
- | ||||||||||
|
- | ||||||||||
| Fate indices |
|
|
|
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||||||||||||||||||||
|
|
- | - | - | |||||||||||||||||||||||||
|
- | - | |||||||||||||||||||||||||||
| Known metabolites |
None
|
|
| Terrestrial ecotoxicology |
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
243 | E3 E = Manufacturers safety data sheets Rat3 = Unverified data of known source |
Moderate | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
| - | |||||||||||
|
- | - | - | ||||||||
| - | |||||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- |
|
- | - | - | ||||||
|
- | ||||||||||
| Aquatic ecotoxicology |
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - |
|
- | - | - | |||
|
- | - | - | ||||||||
|
|
| General |
|
|
|
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
243 | E3 E = Manufacturers safety data sheets Rat3 = Unverified data of known source |
Moderate | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
176 | Q3 Q = Miscellaneous data from online sources Rat3 = Unverified data of known source |
- | ||||||||
|
- | - | - | ||||||||
|
Intravenous LD₅₀ = 150 mg kg⁻¹ bw | E3 E = Manufacturers safety data sheets Rat3 = Unverified data of known source |
- | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | |||||||||
|
- | ||||||||||
|
Aminophylline is rapidly absorbed by the body and converted to theophylline. About 10% of a dose of theophylline is excreted unchanged in the urine. | Q4 Q = Miscellaneous data from online sources 4 = Verified data |
- | ||||||||
| Health issues |
|
|
||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
May cause headaches, nausea, vomiting and grastrointestinal disturbances | ||||||||||||||||||||||||||||
| Handling issues |
|
|
|||
|---|---|---|---|---|
|
IMDG Transport Hazard Class 6,1 Corrosive Incompatible materials with strong oxidising agents Toxic fumes of carbon dioxide, carbon monoxide, nitrogen oxides may be released on heating |
|||
|
Health: H301, H315, H318 | |||
|
- | |||
|
UN2811 | |||
|
Packaging group III (minor danger) | |||
|
Product is chemically stable under ambient conditions |
|
|
|
|
||
|---|---|---|---|
|
aminophylline | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- |
| Record last updated: | 16/09/2025 |
| Contact: | aeru@herts.ac.uk |
| Please cite as: | Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242 |
© Copyright University of Hertfordshire, 2006-2026. All Rights Reserved
Your use of this website and its various databases is subject to the terms detailed in the University of Hertfordshire’s copyright and IPR statement that can be found at https://www.herts.ac.uk/about-us/legal. In addition, your use of this website and its various databases is subject to the terms of this additional Copyright Statement and the database Conditions of use document. Unless explicitly stated otherwise, the content of this website and databases are owned and controlled by the University of Hertfordshire. Site content, including its selection and arrangement, is owned by the University of Hertfordshire and is protected by copyright and other laws. Except as otherwise expressly permitted under copyright law or within the database Conditions of Use document, the content of this site may not be copied, reproduced, republished, downloaded, posted, broadcast or transmitted in any way without first obtaining the University of Hertfordshire’s written permission. By using our databases the user is deemed to have agreed to comply with all of the terms and conditions as described above and within all relevant documentation.



